Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

1.

Immunopathology of highly virulent pathogens: insights from Ebola virus.

Zampieri CA, Sullivan NJ, Nabel GJ.

Nat Immunol. 2007 Nov;8(11):1159-64. Review.

PMID:
17952040
[PubMed - indexed for MEDLINE]
2.

Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection.

Mahanty S, Gupta M, Paragas J, Bray M, Ahmed R, Rollin PE.

Virology. 2003 Aug 1;312(2):415-24.

PMID:
12919746
[PubMed - indexed for MEDLINE]
Free Article
3.

Functional CD8+ T cell responses in lethal Ebola virus infection.

Bradfute SB, Warfield KL, Bavari S.

J Immunol. 2008 Mar 15;180(6):4058-66.

PMID:
18322215
[PubMed - indexed for MEDLINE]
Free Article
4.

Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.

Bray M, Geisbert TW.

Int J Biochem Cell Biol. 2005 Aug;37(8):1560-6. Epub 2005 Mar 7.

PMID:
15896665
[PubMed - indexed for MEDLINE]
5.

Ebola virus: immune mechanisms of protection and vaccine development.

Nyamathi AM, Fahey JL, Sands H, Casillas AM.

Biol Res Nurs. 2003 Apr;4(4):276-81. Review.

PMID:
12698920
[PubMed - indexed for MEDLINE]
6.

Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.

Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY.

J Virol. 2006 Mar;80(6):2738-46.

PMID:
16501083
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.

Hartman AL, Ling L, Nichol ST, Hibberd ML.

J Virol. 2008 Jun;82(11):5348-58. doi: 10.1128/JVI.00215-08. Epub 2008 Mar 19.

PMID:
18353943
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Ebola virus: unravelling pathogenesis to combat a deadly disease.

Hoenen T, Groseth A, Falzarano D, Feldmann H.

Trends Mol Med. 2006 May;12(5):206-15. Epub 2006 Apr 17. Review.

PMID:
16616875
[PubMed - indexed for MEDLINE]
9.

Ebola virus: from discovery to vaccine.

Feldmann H, Jones S, Klenk HD, Schnittler HJ.

Nat Rev Immunol. 2003 Aug;3(8):677-85. Review.

PMID:
12974482
[PubMed - indexed for MEDLINE]
10.

Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B.

J Immunol. 2003 Mar 15;170(6):2797-801.

PMID:
12626527
[PubMed - indexed for MEDLINE]
Free Article
11.

Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells.

Davis KJ, Anderson AO, Geisbert TW, Steele KE, Geisbert JB, Vogel P, Connolly BM, Huggins JW, Jahrling PB, Jaax NK.

Arch Pathol Lab Med. 1997 Aug;121(8):805-19.

PMID:
9278608
[PubMed - indexed for MEDLINE]
12.

3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice.

Bray M, Raymond JL, Geisbert T, Baker RO.

Antiviral Res. 2002 Jul;55(1):151-9.

PMID:
12076759
[PubMed - indexed for MEDLINE]
13.

[Developing methods of specific heterologic immunoglobulins preparation for urgent prevention of Ebola fever and study of their properties].

Cherpunov AA, Kudoiarova-Zubavichene NM, Dedkova LM, Sergeev NN, Netesov SV.

Vestn Ross Akad Med Nauk. 1998;(4):24-9. Russian.

PMID:
9633237
[PubMed - indexed for MEDLINE]
14.

[Dynamics of immunologic indicators in guinea pigs upon administering various preparations of the Ebola virus].

Dadaeva AA, Sizikova LP, Zhukov VA, Chepurnov AA.

Vopr Virusol. 1998 Jul-Aug;43(4):163-9. Russian.

PMID:
9791881
[PubMed - indexed for MEDLINE]
15.

The pathogenesis of Ebola hemorrhagic fever.

Takada A, Kawaoka Y.

Trends Microbiol. 2001 Oct;9(10):506-11. Review.

PMID:
11597453
[PubMed - indexed for MEDLINE]
16.

Human asymptomatic Ebola infection and strong inflammatory response.

Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansoud-Soukate J, Capron M, Debré P, McCormick JB, Georges AJ.

Lancet. 2000 Jun 24;355(9222):2210-5.

PMID:
10881895
[PubMed - indexed for MEDLINE]
17.

Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis.

Ryabchikova E, Kolesnikova L, Smolina M, Tkachev V, Pereboeva L, Baranova S, Grazhdantseva A, Rassadkin Y.

Arch Virol. 1996;141(5):909-21.

PMID:
8678836
[PubMed - indexed for MEDLINE]
18.

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.

Warfield KL, Swenson DL, Olinger GG, Kalina WV, Aman MJ, Bavari S.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S430-7.

PMID:
17940980
[PubMed - indexed for MEDLINE]
Free Article
19.

Ebola virus: the search for vaccines and treatments.

Wilson JA, Bosio CM, Hart MK.

Cell Mol Life Sci. 2001 Nov;58(12-13):1826-41. Review.

PMID:
11766882
[PubMed - indexed for MEDLINE]
20.

A current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment.

Casillas AM, Nyamathi AM, Sosa A, Wilder CL, Sands H.

Biol Res Nurs. 2003 Apr;4(4):268-75. Review.

PMID:
12698919
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk